| 1 |
Huang X, Hu P, Yan F, Zhang J. Establishment and Validation of a Nomogram Based on Negative Lymph Nodes to Predict Survival in Postoperative Patients with non-Small Cell Lung Cancer. Technol Cancer Res Treat 2022;21:153303382210745. [DOI: 10.1177/15330338221074506] [Reference Citation Analysis]
|
| 2 |
Zhou J, Lin Z, Lyu M, Chen N, Liao H, Wang Z, Hao J, Yan C, Liu L. Prognostic value of lymph node ratio in non-small-cell lung cancer: a meta-analysis. Jpn J Clin Oncol 2020;50:44-57. [PMID: 31735973 DOI: 10.1093/jjco/hyz120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 3 |
Zhou X, Wu C, Cheng Q. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer.Lung. 2020;198:839-846. [PMID: 32683563 DOI: 10.1007/s00408-020-00378-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 4 |
Mao Q, Xia W, Dong G, Chen S, Wang A, Jin G, Jiang F, Xu L. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery. J Thorac Cardiovasc Surg 2018;155:1784-1792.e3. [PMID: 29554790 DOI: 10.1016/j.jtcvs.2017.11.098] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 5 |
Xiao W, Liang H, Zhang H, Jia R, Yang Y, Wang Y, Tang P, Yu Z. Ratio between negative and positive lymph nodes is a novel prognostic indicator for patients with esophageal cancer: A Surveillance, Epidemiology and End Results database analysis. Thorac Cancer 2020;11:3490-500. [PMID: 33034409 DOI: 10.1111/1759-7714.13688] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Kang JY, Park JW, Hwang Y, Hahm JY, Park J, Park KS, Seo SB. The H3K4 methyltransferase SETD1A is required for proliferation of non-small cell lung cancer cells by promoting S-phase progression. Biochem Biophys Res Commun 2021;561:120-7. [PMID: 34023776 DOI: 10.1016/j.bbrc.2021.05.026] [Reference Citation Analysis]
|
| 7 |
Cackowski MM, Gryszko GM, Zbytniewski M, Dziedzic DA, Orłowski TM. Alternative methods of lymph node staging in lung cancer: a narrative review. J Thorac Dis 2020;12:6042-53. [PMID: 33209438 DOI: 10.21037/jtd-20-1997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 8 |
Bao M, Song Y, Xia J, Li P, Liu Q, Wan Z. miR-1269 promotes cell survival and proliferation by targeting tp53 and caspase-9 in lung cancer. Onco Targets Ther 2018;11:1721-32. [PMID: 29618932 DOI: 10.2147/OTT.S157715] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 9 |
Zhou X, Wu C, Cheng Q. Negative Lymph Node Count Predicts Survival of Resected Non-small Cell Lung Cancer. Lung 2020;198:839-46. [DOI: 10.1007/s00408-020-00378-7] [Reference Citation Analysis]
|
| 10 |
Zhou P, Hu J, Wang X, Wang J, Zhang Y, Wang C. Epidermal growth factor receptor expression affects proliferation and apoptosis in non-small cell lung cancer cells via the extracellular signal-regulated kinase/microRNA 200a signaling pathway. Oncol Lett 2018;15:5201-7. [PMID: 29552158 DOI: 10.3892/ol.2018.7961] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
